John M Burke, MD from Rocky Mountain Cancer Centers discusses a new study with diffuse large B-cell lymphoma and improvements taking Polatuzumab with Bendamustine and Rituximab at the 2017 American Society of Hematology.
John M Burke, MD from Rocky Mountain Cancer Centers discusses a new study with diffuse large B-cell lymphoma and improvements taking Polatuzumab with Bendamustine and Rituximab at the 2017 American Society of Hematology.